Navigation Links
Bard EP XT

ProductsBard EP XT
Company C. R. Bard, Inc.
Item Bard EP XT
Features Available in 6F and 7F shafts, as well as 2mm and 4mm distal tip electrodes. Patented curving mechanism. Thumbwheel control. Convenient Easy-Mate connectors. Curve shape control technology.
Description The reliable, easy-to-steer Bart EPXT catheter offers an exceptional blend of shaft stability and curve control for faster, more accurate mapping. Bard's exclusive point-of-tip actuation control supplies exceptional levels of tip response and control. This extraordinary family of small, medium and long-reach curves provides clinical versatility and reliable performance.
Info C. R. Bard, Inc.
Customer Service: (800) 367-2273
Web site: http://www.crbard.com

Related medicine products :

1. CODMAN Steerable Neuroendoscope
2. EPT-DX Steerable Diagnostic Catheters
3. Inquiry Steerable Diagnostic Catheters
4. A-Focus Steerable Diagnostic Catheters
5. EPT-Dx Steerable Diagnostic Catheters
6. Inquiry H Steerable Diagnostic Catheters
7. Luma-Cath Lumen Diagnostic Mapping Catheters Fixed and Steerable Curves
8. Attain Prevail™ Steerable Catheter Left-Heart Lead Delivery System
9. Fathom Steerable Guidewire
10. Reflexion™ Steerable Catheters
11. Agilis Steerable Introducer
TAG: Bard
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
Medicine Products:
(Date:1/8/2009)...rrorist Missile Strikes , , NEW YORK, Jan. 8 /...s (UJC) and the Jewish Federations of North Americ...humanitarian and social needs in southern Israel, ... solidarity with Israelis during the current confl...rol of the Gaza Strip. , , The funds will enha...
(Date:1/8/2009)...an. 8 The National eHealth Collabo...nced the results of its organizational leadership ... CEO of Prematics, Inc., was elected to serve as V...ctors. The Collaborative builds on the accomplish... (AHIC), a federal advisory committee established ...
(Date:1/8/2009)... Jan 8 Wyeth (NYSE: WY... Morgan Healthcare Conference on Wednesday, Januar... for Wyeth will be Geno Germano, President, U.S. a...icals. , , Wyeth,s presentation will be webcas...ble for replay following the conference. , , Wy...
(Date:1/8/2009)... Ripa Will Be Celebrity Host of Show at Nassau Col...nd Up for a Cure today announced the first of its...h Barry Manilow , in partnership with The Breast... be held on February 14th, 2009 at Nassau Coliseum...Monday November 10th through Ticketmaster.com or b...
Breaking Medicine News(10 mins):Health News:UJC and Jewish Federations of North America Commit $10 Million for Needs in Southern Israel 2Health News:Kevin Hutchinson Elected Vice Chair of Board of Directors for National eHealth Collaborative 2Health News:Wyeth to Present at the JP Morgan Healthcare Conference 2Health News:Barry Manilow Brings Valentine's and Music to New York With Concert to Raise Funds for Breast Cancer Research 2
...ti-clotting drugs to stroke victims could greatly ...break up clots are the only effective treatment in...er, they must be administered before brain cells d...begin within three hours of the onset of the strok...
...s created using information taken from a monkey ge... AIDS virus in a laboratory experiment. The resea...trocyclin,'' was once produced naturally in human ...of an ancient mutation. Alexander Cole, a scientis...
...re of your hair as you do of your skin, say hair e...s that the outer layer of the hair - the cuticle -... look lifeless, dry and faded.// Hair damage occur... drying to environmental pollution and sun exposur...
...ke people smarter by improving memory and brain pe... found the ability to recall remembered words impr...entists from the University of Northumbria, in New... theories. One is that chewing raises the heart b...
Other Medicine News:Health News:Scientists found ancient Human Germ Killer 2
(Date:1/8/2009)... be Quark,s second indication with clinical-stage,... , , FREMONT, Calif., Jan. 8 Q...armaceutical company discovering and developing no...day announced that it has initiated patient dosing...ystemically administered siRNA drug candidate QPI-...
(Date:1/8/2009)...fy and Validate Novel Gene Expression Biomarkers I...ession Platform , , FREMONT, Calif., Jan. 8 /PR...OTC Bulletin Board: WGBS), a leading developer of ... biology and stem cell research systems, today ann...h the University of Texas Southwestern Medical Ce...
(Date:1/8/2009)...wswire/ -- If you are taking prescription medicine...alf of the people taking,prescription medicine do... -- they forget, are busy with other priorities, o... has been called the Achilles heel of modern,heal...mented, "Drugs don,t,work in people who don,t tak...
(Date:1/8/2009)...MBUS, Ohio, Jan. 8 IntelligentMDx a... acid assays, today announced that verification st...Assay are complete. , , Under the verification...ficity and reproducibility and robustness of the B...ta obtain agreed with internally generated analyti...
Breaking Medicine Technology:Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 2Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 3Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 4WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 2WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 3WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 4WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 5Good Medicine: Smarter Smartphones for People With Chronic Disease 2Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed 2Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed 3Arena Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical Biotechnology and Medical Device Conference 10460 1Arena Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical Biotechnology and Medical Device Conference 10460 2Arena Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical Biotechnology and Medical Device Conference 10460 3Reckitt Benckiser Completes Acquisition of Adams Respiratory Therapeutics Inc 10456 1Reckitt Benckiser Completes Acquisition of Adams Respiratory Therapeutics Inc 10456 2NutraCea Files Universal Shelf Registration Statement 10451 1NutraCea Files Universal Shelf Registration Statement 10451 2ABC Drama Eli Stone Tackles Autism Mercury Controversy 10447 1ABC Drama Eli Stone Tackles Autism Mercury Controversy 10447 2
...nnounced positive,interim results from the ongoing...ALX-0081, an anti-thrombotic treatment.,ALX-0081 i...,Nanobody® targeting von Willebrand Factor (vW...ients with acute coronary,syndrome. , The Phase I ...safety, tolerability and pharmacokinetics of ALX-0...
...ovakia have,been able to derive mesenchymal stem c...er them into “suicide genes” that, see...., This gene therapy approach is a novel way to at...ection techniques and,treatments, the researchers ... journal of the American Association for Cancer,Re...
Other Medicine Technology:Ablynx Announces Interim Results of First Nanobody Phase I Study of,ALX-0081 (ANTI-VWF) 2Fat Kills Cancer: Turning Stem Cells from Fat Tissue into,Personalized, Cancer-Targeted Therapeutics 2Fat Kills Cancer: Turning Stem Cells from Fat Tissue into,Personalized, Cancer-Targeted Therapeutics 3